119 related articles for article (PubMed ID: 11601905)
1. A single amino acid substitution in the viral polymerase creates a temperature-sensitive and attenuated recombinant bovine parainfluenza virus type 3.
Haller AA; MacPhail M; Mitiku M; Tang RS
Virology; 2001 Sep; 288(2):342-50. PubMed ID: 11601905
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of the recombinant human parainfluenza virus type 3 cp45 candidate vaccine virus is augmented by importation of the respiratory syncytial virus cpts530 L polymerase mutation.
Skiadopoulos MH; Surman SR; St Claire M; Elkins WR; Collins PL; Murphy BR
Virology; 1999 Jul; 260(1):125-35. PubMed ID: 10405364
[TBL] [Abstract][Full Text] [Related]
3. Long nucleotide insertions between the HN and L protein coding regions of human parainfluenza virus type 3 yield viruses with temperature-sensitive and attenuation phenotypes.
Skiadopoulos MH; Surman SR; Durbin AP; Collins PL; Murphy BR
Virology; 2000 Jun; 272(1):225-34. PubMed ID: 10873765
[TBL] [Abstract][Full Text] [Related]
4. Expression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel attenuated virus vaccine vector.
Haller AA; Miller T; Mitiku M; Coelingh K
J Virol; 2000 Dec; 74(24):11626-35. PubMed ID: 11090161
[TBL] [Abstract][Full Text] [Related]
5. Genetic stability of RSV-F expression and the restricted growth phenotype of a live attenuated PIV3 vectored RSV vaccine candidate (MEDI-534) following restrictive growth in human lung cells.
Nelson CL; Tang RS; Stillman EA
Vaccine; 2013 Aug; 31(36):3756-62. PubMed ID: 23623857
[TBL] [Abstract][Full Text] [Related]
6. Determinants of the host range restriction of replication of bovine parainfluenza virus type 3 in rhesus monkeys are polygenic.
Skiadopoulos MH; Schmidt AC; Riggs JM; Surman SR; Elkins WR; St Claire M; Collins PL; Murphy BR
J Virol; 2003 Jan; 77(2):1141-8. PubMed ID: 12502830
[TBL] [Abstract][Full Text] [Related]
7. Recovery of infectious human parainfluenza virus type 3 from cDNA.
Durbin AP; Hall SL; Siew JW; Whitehead SS; Collins PL; Murphy BR
Virology; 1997 Sep; 235(2):323-32. PubMed ID: 9281512
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the C, D, and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates.
Durbin AP; McAuliffe JM; Collins PL; Murphy BR
Virology; 1999 Sep; 261(2):319-30. PubMed ID: 10497117
[TBL] [Abstract][Full Text] [Related]
9. Replacement of the ectodomains of the hemagglutinin-neuraminidase and fusion glycoproteins of recombinant parainfluenza virus type 3 (PIV3) with their counterparts from PIV2 yields attenuated PIV2 vaccine candidates.
Tao T; Skiadopoulos MH; Davoodi F; Riggs JM; Collins PL; Murphy BR
J Virol; 2000 Jul; 74(14):6448-58. PubMed ID: 10864657
[TBL] [Abstract][Full Text] [Related]
10. A recombinant human parainfluenza virus type 3 (PIV3) in which the nucleocapsid N protein has been replaced by that of bovine PIV3 is attenuated in primates.
Bailly JE; McAuliffe JM; Durbin AP; Elkins WR; Collins PL; Murphy BR
J Virol; 2000 Apr; 74(7):3188-95. PubMed ID: 10708435
[TBL] [Abstract][Full Text] [Related]
11. Sequence determination and molecular analysis of two strains of bovine parainfluenza virus type 3 that are attenuated for primates.
Bailly JE; McAuliffe JM; Skiadopoulos MH; Collins PL; Murphy BR
Virus Genes; 2000; 20(2):173-82. PubMed ID: 10872880
[TBL] [Abstract][Full Text] [Related]
12. Current status of vaccines for parainfluenza virus infections.
Sato M; Wright PF
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S123-5. PubMed ID: 18820572
[TBL] [Abstract][Full Text] [Related]
13. Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infants.
Lee MS; Greenberg DP; Yeh SH; Yogev R; Reisinger KS; Ward JI; Blatter MM; Cho I; Holmes SJ; Cordova JM; August MJ; Chen W; Mehta HB; Coelingh KL; Mendelman PM
J Infect Dis; 2001 Oct; 184(7):909-13. PubMed ID: 11509996
[TBL] [Abstract][Full Text] [Related]
14. Three amino acid substitutions in the L protein of the human parainfluenza virus type 3 cp45 live attenuated vaccine candidate contribute to its temperature-sensitive and attenuation phenotypes.
Skiadopoulos MH; Durbin AP; Tatem JM; Wu SL; Paschalis M; Tao T; Collins PL; Murphy BR
J Virol; 1998 Mar; 72(3):1762-8. PubMed ID: 9499025
[TBL] [Abstract][Full Text] [Related]
15. Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates.
Schmidt AC; McAuliffe JM; Huang A; Surman SR; Bailly JE; Elkins WR; Collins PL; Murphy BR; Skiadopoulos MH
J Virol; 2000 Oct; 74(19):8922-9. PubMed ID: 10982335
[TBL] [Abstract][Full Text] [Related]
16. Comparison of identical temperature-sensitive mutations in the L polymerase proteins of sendai and parainfluenza3 viruses.
Feller JA; Smallwood S; Skiadopoulos MH; Murphy BR; Moyer SA
Virology; 2000 Oct; 276(1):190-201. PubMed ID: 11022007
[TBL] [Abstract][Full Text] [Related]
17. A live attenuated chimeric recombinant parainfluenza virus (PIV) encoding the internal proteins of PIV type 3 and the surface glycoproteins of PIV type 1 induces complete resistance to PIV1 challenge and partial resistance to PIV3 challenge.
Tao T; Skiadopoulos MH; Durbin AP; Davoodi F; Collins PL; Murphy BR
Vaccine; 1999 Mar; 17(9-10):1100-8. PubMed ID: 10195620
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the GDD motif of rubella virus putative RNA-dependent RNA polymerase affect virus replication.
Wang X; Gillam S
Virology; 2001 Jul; 285(2):322-31. PubMed ID: 11437666
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.
Parks CL; Latham T; Cahill A; O'neill RE; Passarotti CJ; Buonagurio DA; Bechert TM; D'Arco GA; Neumann G; Destefano J; Arendt HE; Obregon J; Shutyak L; Hamm S; Sidhu MS; Zamb TJ; Udem SA
Virology; 2007 Oct; 367(2):275-87. PubMed ID: 17599381
[TBL] [Abstract][Full Text] [Related]
20. Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicity.
Buchholz UJ; Biacchesi S; Pham QN; Tran KC; Yang L; Luongo CL; Skiadopoulos MH; Murphy BR; Collins PL
J Virol; 2005 Jun; 79(11):6588-97. PubMed ID: 15890897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
